Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Mamonkin

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|March 4, 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational applicationJiali Sun, Leslie E Huye, Natalia Lapteva, et al.
Blood|December 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomasLaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, et al.
The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
The Journal of Clinical Investigation|July 1, 2021
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
The Journal of Clinical Investigation|July 3, 2019
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Blood|August 1, 2022
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignanciesAbdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, et al.
Immunology Letters|October 12, 2010
FCRL6 receptor: expression and associated proteinsSergey V Kulemzin, Alina Y Zamoshnikova, Mariya Y Yurchenko, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Nature|February 22, 2019
Retraction Note: A homing system targets therapeutic T cells to brain cancerHeba Samaha, Antonella Pignata, Kristen Fousek, et al.
Nature|September 7, 2018
A homing system targets therapeutic T cells to brain cancerHeba Samaha, Antonella Pignata, Kristen Fousek, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|March 4, 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational applicationJiali Sun, Leslie E Huye, Natalia Lapteva, et al.
Blood|December 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomasLaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, et al.
The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
The Journal of Clinical Investigation|July 1, 2021
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
The Journal of Clinical Investigation|July 3, 2019
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Blood|August 1, 2022
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignanciesAbdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, et al.
Immunology Letters|October 12, 2010
FCRL6 receptor: expression and associated proteinsSergey V Kulemzin, Alina Y Zamoshnikova, Mariya Y Yurchenko, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Nature|February 22, 2019
Retraction Note: A homing system targets therapeutic T cells to brain cancerHeba Samaha, Antonella Pignata, Kristen Fousek, et al.
Nature|September 7, 2018
A homing system targets therapeutic T cells to brain cancerHeba Samaha, Antonella Pignata, Kristen Fousek, et al.
Pageof 6